EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CCL5 deficiency aggravates acute DSS-induced colitis by restricting IL-33-induced formation of Tregs in intestinal tract

Yang Luo, Ting-Yue Gong, Yong-Heng Zhao, Hao Li, Guang-Yao Ye, Zi-Zhen Zhang, Min-Hao Yu, Yan Zhang, Ming Zhong iD

Clinical Science · 2026

DOI: 10.1042/cs20256734 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Science, 2026. Verfasst von Yang Luo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, P.R., 200127, China. Hauptthemen laut MEDLINE: Interleukin-33, Chemokine CCL5, T-Lymphocytes, Regulatory, Colitis, Ulcerative. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis (UC) is a chronic inflammatory disease of the gastrointestinal tract, characterized by ongoing intestinal inflammation, epithelial damage, and mucosal injury. Despite the identification of C-C motif chemokine ligand 5 (CCL5) as a key mediator in UC, the precise mechanisms underlying its role in immune activation and inflammation remain unclear. This study aimed to investigate CCL5 as a critical immune modulator in UC, focusing on its effects on immune cell activation, particularly regulatory T cell (Treg) formation, and the molecular pathways involved in these processes. Using the dextran sulfate sodium salt (DSS)-induced UC model and CCL5 knockout (Ccl5-KO) mice, we demonstrated that CCL5 deficiency exacerbates intestinal inflammation during the acute phase of colitis, partly due to impaired interleukin-33 (IL-33)-induced Treg formation. In addition, we observed a positive correlation between CCL5 expression and forkhead box protein 3 (FOXP3) levels in inflamed colon tissues of UC patients, suggesting a role for CCL5 in Treg regulation. Mechanistically, CCL5 deficiency disrupted the PI3K/Akt/NF-κB signaling pathway, resulting in reduced IL-33 expression, which in turn impaired CD4+ T cell activation and FOXP3+ Treg formation via the JAK1/STAT5 pathway. In vivo rescue experiments confirmed that restoring IL-33 signaling could alleviate inflammation and partially recover Treg function. Collectively, these findings highlight CCL5 as a novel immune modulator of Treg formation and immune responses in UC and suggest that targeting CCL5 may offer a promising therapeutic strategy for managing UC and related inflammatory diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-33Chemokine CCL5T-Lymphocytes, RegulatoryColitis, UlcerativeColitisAnimalsDextran SulfateMice, KnockoutMice, Inbred C57BLHumansSignal TransductionDisease Models, AnimalForkhead Transcription FactorsNF-kappa BMiceMaleColonProto-Oncogene Proteins c-aktPhosphatidylinositol 3-Kinases

Stichwörter der Autor:innen

CCL5IL33Tregs formationacute DSS-induced colitisulcerative colitis

Substanzen

Interleukin-33Chemokine CCL5Dextran SulfateCcl5 protein, mouseIl33 protein, mouseForkhead Transcription FactorsNF-kappa BFoxp3 protein, mouseCCL5 protein, humanProto-Oncogene Proteins c-akt

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, P.R., 200127, China.
  • State Key Laboratory of Oncogenes and Related Genes, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, P.R., China.
  • Department of General Surgery, Gongli Hospital, 219 Miaopu Road, Pudong New District, Shanghai, P.R., 200135, China.

ORCID-Profile: Ming Zhong

Förderung

  • National Natural Science Foundation of China
  • Shanghai Municipal Health Commission

Zitieren

APA

Luo, Y., Gong, T. Y., Zhao, Y. H., Li, H., Ye, G. Y., Zhang, Z. Z., Yu, M. H., Zhang, Y., & Zhong, M. (2026). CCL5 deficiency aggravates acute DSS-induced colitis by restricting IL-33-induced formation of Tregs in intestinal tract. Clinical Science. https://doi.org/10.1042/cs20256734

Vancouver

Luo Y, Gong TY, Zhao YH, Li H, Ye GY, Zhang ZZ, et al. CCL5 deficiency aggravates acute DSS-induced colitis by restricting IL-33-induced formation of Tregs in intestinal tract. Clinical Science. 2026. doi:10.1042/cs20256734

BibTeX
@article{Luo2026,
  author = {Luo, Yang and Gong, Ting-Yue and Zhao, Yong-Heng and Li, Hao and Ye, Guang-Yao and Zhang, Zi-Zhen and Yu, Min-Hao and Zhang, Yan and Zhong, Ming},
  title = {CCL5 deficiency aggravates acute DSS-induced colitis by restricting IL-33-induced formation of Tregs in intestinal tract},
  journal = {Clinical Science},
  year = {2026},
  doi = {10.1042/cs20256734}
}
Kostenlos starten →